Advertisement

IAI, Aerotor sign MOU to advance unmanned technologies

By Arie Egozi

The growing demand for advanced multi rotor unmanned systems bring Israel Aerospace Industries (IAI) to cooperate with companies that specialize in these systems.

 

IAI has signed a Memorandum of Understanding (MOU) with Israeli company Aerotor that includes the development of products and promotion of their commercial cooperation.

 

 

Within the framework of the MOU,  advanced drone systems for a variety of tactical military missions for users on land, at sea and in the air will be developed. The agreement includes the engineering development and marketing of Aerotor’s Apus multicopter, which is based on a unique configuration which uses a central heavy-fuel propulsion system piloted through a variable-pitch mechanism. This provides a distinct operational advantage in terms of the payload that can be carried, flight duration, and maneuverability.

 

 

CEO of Israel Aerospace Industries, Boaz Levy: “Cooperation between IAI and Aerotor will allow us to leverage synergies in our product lines and promote the business growth of both companies. Both in normal times and during times of emergency, IAI continues to provide its customers with the best solutions. Collaboration agreements like the one we have just signed bring us to the forefront in all the fields in which we are active, thus increasing our portfolio of solutions.”

 

 

Chairperson and CEO of Aerotor Unmanned Systems, Raz Geva: “Aerotor develops path breaking platforms in terms of their flight duration and the payload they can carry. Together with IAI as a leading partner in the aviation sector and in unmanned platforms in both the military and paramilitary fields, we will expand our customer base around the world. Aerotor and IAI have already begun to cooperate, and together, the two companies will create new business opportunities, for the benefit of both our companies.”

 

Tags:

Advertisement

Advertisement

Advertisement

Related news & articles

Advertisement

Advertisement

Latest news

Advertisement

Advertisement

Featured

Advertisement